NCT05669638

A Prospective Study to Observe Adverse Effects in Patients Receiving Anti-PD1 Immunotherapy

• Status: Unknown
• Phase: —
• Study type: Observational
• Enrollment: 80 (estimated)
• Sponsor: Xuanwu Hospital, Beijing · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The goal of this observational study is to learn about in the development process of adverse reactions of anti-PD1 immunotherapy. The main question it aims to observe: * The autoantibody profile of patients * The adverse reactions of patients * The changes of immune cells and cytokine in patients

Detailed description

The goal of this observational study is to learn about the development process of adverse reactions of anti-PD1 immunotherapy. The main question it aims to observe: * The autoantibody profile of patients * The adverse reactions of patients * The changes of immune cells and cytokine in patients (e.g., T cell, B cell, IL-6, etc.)

Conditions

• Immunotherapy
• ADR

Timeline

• Start date: 2023-05-01
• Primary completion: 2025-05-01
• Completion: 2025-05-01
• First posted: 2023-01-03
• Last updated: 2024-02-09

Locations

1 site across 1 country: China